2.18
Creative Medical Technology Holdings Inc Stock (CELZ) Forecast
The Creative Medical Technology Holdings Inc (CELZ) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.155, representing a +90.60% increase from the current price of $2.18. The highest analyst price target is $4.2512, and the lowest is $4.0589.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CELZ Price Target
Average 7.8327
(+259.30% Upside)
Is Creative Medical Technology Holdings Inc (CELZ) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 55.58 | Neutral |
STOCH(9,6) | 55.57 | Neutral |
STOCHRSI(14) | 100.00 | Sell |
MACD(12,26) | -0.0383 | Buy |
ADX(14) | 9.8689 | Neutral |
William %R | -19.61 | Sell |
CCI(14) | 313.40 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
2.0216
Buy
|
2.0387
Buy
|
MA20 |
2.0218
Buy
|
2.0425
Buy
|
MA50 |
2.0935
Buy
|
2.285
Sell
|
MA100 |
2.8981
Sell
|
2.6156
Sell
|
MA200 |
3.0015
Sell
|
3.0337
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, CELZ could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on CELZ, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 55.58 indicates that CELZ is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.57 indicates that CELZ is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CELZ is oversold. This suggests that CELZ price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 9.8689 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 313.4 indicates that CELZ is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CELZ price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Creative Medical Technology Holdings Inc financial reports and earnings history, Creative Medical Technology Holdings Inc (CELZ) stock could reach $10.37 by 2030, $34.59 by 2040 and $36.39 by 2050. See the projected annual prices until 2050 of the Creative Medical Technology Holdings Inc stock below:
- Creative Medical Technology Holdings Inc (CELZ) is expected to reach an average price of $24.75 in 2035, with a high prediction of $25.07 and a low estimate of $24.44. This indicates an $1,035% rise from the last recorded price of $2.18.
- Creative Medical Technology Holdings Inc (CELZ) stock is projected to chart a bullish course in 2040, with an average price target of $32.94, representing an $1,411% surge from its current level. The forecast ranges from a conservative $31.85 to a sky-high $34.59.
- Our analysts predict Creative Medical Technology Holdings Inc (CELZ) to jump 1,439% by 2045, soaring from $32.82 to an average price of $33.54, potentially reaching $34.02. While $32.82 is the low estimate, the potential upside is significant.
- Creative Medical Technology Holdings Inc (CELZ) stock is expected to climb by 2050, reaching an average of $36.37, a $1,568% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.39 and $35.76, respectively, highlighting the market's uncertainty.
Creative Medical Technology Holdings Inc Stock (CELZ) Year by Year Forecast
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2025
Creative Medical Technology Holdings Inc Stock (CELZ) is expected to reach an average price of $4.5825 in 2025, with a high prediction of $5.4165 and a low estimate of $3.7485. This indicates an +110.21% rise from the last recorded price of $2.18.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
July, 2025 | $4.2277 | $4.0589 | $4.2512 | +93.93% |
August, 2025 | $4.3842 | $4.2309 | $4.4321 | +101.11% |
September, 2025 | $4.5137 | $4.3752 | $5.3025 | +107.05% |
October, 2025 | $4.5457 | $4.4559 | $4.6345 | +108.52% |
November, 2025 | $4.7757 | $4.5265 | $5.4165 | +119.07% |
December, 2025 | $4.7994 | $4.7285 | $4.9075 | +120.15% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2026
The predicted value for Creative Medical Technology Holdings Inc (CELZ) in 2026 is set at an average of $10.07. Estimates vary from a peak of $15.47 to a trough of $4.6775, indicating an +362.08% surge from the present price of $2.18.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $9.1909 | $4.6775 | $11.01 | +321.60% |
February, 2026 | $10.16 | $8.6013 | $10.25 | +366.17% |
March, 2026 | $9.644 | $9.367 | $11.16 | +342.39% |
April, 2026 | $9.316 | $8.7148 | $9.7844 | +327.34% |
May, 2026 | $9.6576 | $9.2977 | $11.61 | +343.01% |
June, 2026 | $9.1292 | $8.9692 | $9.838 | +318.77% |
July, 2026 | $9.2912 | $9.00 | $9.548 | +326.20% |
August, 2026 | $9.6528 | $9.2228 | $11.52 | +342.79% |
September, 2026 | $9.3248 | $9.2044 | $9.8432 | +327.74% |
October, 2026 | $9.3357 | $9.2752 | $9.4663 | +328.24% |
November, 2026 | $11.44 | $9.0568 | $15.47 | +424.68% |
December, 2026 | $10.50 | $10.01 | $11.95 | +381.65% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Creative Medical Technology Holdings Inc (CELZ) is $8.8024, with a high forecast of $10.93 and a low forecast of $6.678. This indicates an +303.78% increase from the last price of $2.18.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $10.28 | $9.6288 | $10.93 | +371.46% |
February, 2027 | $8.2824 | $6.7708 | $8.9524 | +279.93% |
March, 2027 | $7.0764 | $7.0549 | $8.7249 | +224.60% |
April, 2027 | $7.2596 | $6.678 | $7.688 | +233.01% |
May, 2027 | $9.0827 | $6.8412 | $9.5027 | +316.64% |
June, 2027 | $7.9967 | $7.8067 | $10.79 | +266.82% |
July, 2027 | $6.9899 | $6.9094 | $8.0975 | +220.64% |
August, 2027 | $6.9812 | $6.9107 | $7.1023 | +220.24% |
September, 2027 | $6.962 | $6.7739 | $7.2239 | +219.36% |
October, 2027 | $7.242 | $6.9669 | $7.3003 | +232.20% |
November, 2027 | $7.3615 | $7.244 | $7.3835 | +237.68% |
December, 2027 | $7.3074 | $7.2978 | $7.5275 | +235.20% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2028
In 2028, Creative Medical Technology Holdings Inc (CELZ) is projected to reach an average price of $11.45, with a high projection of $15.58 and a low estimate of $7.3198. This indicates an +425.13% rise from the last price of $2.18.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $7.4385 | $7.3198 | $7.5022 | +241.22% |
February, 2028 | $7.5937 | $7.4714 | $7.7922 | +248.34% |
March, 2028 | $7.7875 | $7.6097 | $7.9178 | +257.22% |
April, 2028 | $8.0082 | $7.7847 | $8.0317 | +267.35% |
May, 2028 | $8.6249 | $8.0318 | $9.185 | +295.64% |
June, 2028 | $8.5362 | $8.4424 | $8.7258 | +291.57% |
July, 2028 | $8.5913 | $8.4608 | $8.6413 | +294.10% |
August, 2028 | $8.9353 | $8.6021 | $9.5029 | +309.88% |
September, 2028 | $9.0286 | $8.9169 | $9.0959 | +314.16% |
October, 2028 | $13.50 | $8.9475 | $15.30 | +519.34% |
November, 2028 | $14.44 | $12.93 | $15.58 | +562.19% |
December, 2028 | $13.51 | $13.30 | $14.97 | +519.67% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2029
The 2029 price forecast for Creative Medical Technology Holdings Inc Stock (CELZ) is $14.96 on average, with a high prediction of $20.66 and a low estimate of $9.2662. This represents an +586.32% increase from the previous price of $2.18.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $14.57 | $13.23 | $16.20 | +568.48% |
February, 2029 | $14.40 | $13.96 | $14.87 | +560.37% |
March, 2029 | $14.17 | $13.71 | $14.48 | +549.96% |
April, 2029 | $14.13 | $13.78 | $14.37 | +548.28% |
May, 2029 | $14.50 | $14.09 | $16.45 | +564.97% |
June, 2029 | $14.35 | $14.21 | $14.71 | +558.24% |
July, 2029 | $14.44 | $14.32 | $14.57 | +562.48% |
August, 2029 | $15.78 | $14.18 | $20.66 | +623.70% |
September, 2029 | $15.79 | $15.37 | $16.43 | +624.31% |
October, 2029 | $9.525 | $9.425 | $16.24 | +336.93% |
November, 2029 | $10.01 | $9.2662 | $11.49 | +359.16% |
December, 2029 | $9.7146 | $9.6931 | $10.53 | +345.62% |
Creative Medical Technology Holdings Inc Stock (CELZ) Price Forecast for 2030
Creative Medical Technology Holdings Inc Stock (CELZ) is expected to reach an average price of $11.48 in 2030, with a high forecast of $13.61 and a low forecast of $9.357. This signifies an +426.77% surge from the last price of $2.18.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $9.8905 | $9.357 | $10.37 | +353.69% |
February, 2030 | $12.37 | $9.6017 | $13.61 | +467.22% |
March, 2030 | $10.90 | $10.71 | $12.74 | +400.00% |
April, 2030 | $9.9749 | $9.8944 | $11.02 | +357.56% |
May, 2030 | $9.8819 | $9.8609 | $10.31 | +353.30% |
June, 2030 | $10.13 | $9.913 | $10.33 | +364.70% |
July, 2030 | $10.57 | $10.16 | $10.59 | +385.05% |
August, 2030 | $10.74 | $10.53 | $10.76 | +392.75% |
September, 2030 | $10.74 | $10.73 | $10.94 | +392.71% |
October, 2030 | $11.04 | $10.80 | $11.05 | +406.29% |
November, 2030 | $11.26 | $11.05 | $11.35 | +416.60% |
December, 2030 | $11.49 | $11.30 | $11.62 | +426.90% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):